Literature DB >> 3349233

Actions of vanadate on vascular tension and sodium pump activity in cat isolated cerebral and femoral arteries.

C F Sánchez-Ferrer1, J Marín, M Lluch, A Valverde, M Salaices.   

Abstract

1. The mechanisms involved in the responses induced by sodium vanadate (Va3 VO4) on cat cerebral and femoral arteries were studied. The possibility that these responses were due to Na+, K+-ATPase inhibition was investigated by measuring the effect of vanadate on [3H]-ouabain binding to arterial membrane fractions, K+-induced vasodilatation and ouabain-sensitive 86Rb+ uptake. 2. The vanadium compounds (Na3VO4, VOSO4, VCl3 and O5V3) induced similar, concentration-dependent contractions in each kind of artery, the cerebral vessels being the most sensitive to these compounds. 3. Exposure of the arteries to a low-Na+ (25 mM) solution suppressed the contraction caused by vanadate in femoral but not in cerebral arteries. 4. Vanadate-induced contractions were reduced in Ca2+-free medium but remained unaffected by 3 x 10(-6) M phentolamine, reserpine pretreatment or 3 x 10(-6) M verapamil in both kinds of artery. 5. The addition of 7.5 mM K+ to the arteries immersed in a K+-free solution induced vasodilatation, which was not modified by 10(-3) M vanadate. 6. The consecutive administration of ouabain (10(-4) M) and vanadate (10(-3) M) (or vice versa), or the simultaneous administration of both agents (10(-8) to 10(-3) M) appeared to produce an additive contraction in both types of artery. 7. Vanadate (10(-7) to 10(-3) M) did not displace the [3H]-ouabain binding to arterial membrane fractions of these arteries, whereas 10(-4) M ouabain did. 8. In both kinds of artery, total 86Rb+ uptake was reduced by ouabain (10(-8) to 10(-3) M), in a concentration-dependent manner, whereas it was not modified by vanadate (10(-8)-10(-3) M). 9. These results suggest that vanadate induces contraction in both types of artery by a mechanism unrelated to Na+, K+-ATPase inhibition. Such a mechanism is likely to be related to inhibition of the Ca2-ATPase of the cell membrane and/or the sarcoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349233      PMCID: PMC1853769          DOI: 10.1111/j.1476-5381.1988.tb11404.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Vanadate inhibition of sarcoplasmic reticulum Ca2+-ATPase and other ATPases.

Authors:  S G O'Neal; D B Rhoads; E Racker
Journal:  Biochem Biophys Res Commun       Date:  1979-08-13       Impact factor: 3.575

2.  Stimulatory effect of vanadate on (Na+ + K+)-ATPase activity and on 3H-ouabain-binding in a cat heart cell membrane preparation.

Authors:  E Erdmann; W Krawietz; G Phillipp; I Hackbarth; W Schmitz; H Scholz
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

Review 3.  Sodium-calcium interactions in mammalian smooth muscle.

Authors:  C Van Breemen; P Aaronson; R Loutzenhiser
Journal:  Pharmacol Rev       Date:  1978-06       Impact factor: 25.468

4.  Kinetics of inhibition of NaK-ATPase by Mg(2+), K+, and vanadate.

Authors:  G H Bond; P M Hudgins
Journal:  Biochemistry       Date:  1979-01-23       Impact factor: 3.162

5.  Vanadate inhibits the red cell (Na+, K+) ATPase from the cytoplasmic side.

Authors:  L C Cantley; M D Resh; G Guidotti
Journal:  Nature       Date:  1978-04-06       Impact factor: 49.962

6.  Commercial ATP containing traces of vanadate alters the response of (Na+ + K+) ATPase to external potassium.

Authors:  L A Beaugé; I M Glynn
Journal:  Nature       Date:  1978-04-06       Impact factor: 49.962

7.  Contractile response and amine receptor mechanisms in isolated middle cerebral artery of the cat.

Authors:  K C Nielsen; C Owman
Journal:  Brain Res       Date:  1971-03-19       Impact factor: 3.252

Review 8.  The electrogenic Na+, K+-pump in smooth muscle: physiologic and pharmacologic significance.

Authors:  W W Fleming
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

9.  Mechanisms of ouabain-induced arterial muscle contraction.

Authors:  N Toda
Journal:  Am J Physiol       Date:  1980-08

10.  Noradrenaline release induced by ouabain and vanadate in cat cerebral and peripheral arteries.

Authors:  J Marín; C F Sánchez-Ferrer; M Salaices; I Rico
Journal:  Gen Pharmacol       Date:  1986
View more
  14 in total

1.  Trials of the bronchodilator activity of the isoenzyme-selective phosphodiesterase inhibitor AH 21-132 in healthy volunteers during a methacholine challenge test.

Authors:  R W Foster; K Rakshi; J R Carpenter; R C Small
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

2.  AlF4- induces Ca2+ oscillations in guinea-pig ileal smooth muscle.

Authors:  B Himpens; L Missiaen; G Droogmans; R Casteels
Journal:  Pflugers Arch       Date:  1991-02       Impact factor: 3.657

3.  AlF-4 inhibits the accumulation of Ca in the endoplasmic reticulum in intact myometrial strips, but not in the rabbit ear artery.

Authors:  L Missiaen; Y Kanmura; F Wuytack; L Raeymaekers; I Declerck; G Droogmans; R Casteels
Journal:  Pflugers Arch       Date:  1989-08       Impact factor: 3.657

4.  Contractile effects of vanadate on aorta rings from virgin and pregnant rats.

Authors:  J St-Louis; B Sicotte; E Breton; A K Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 5.  Smooth muscle contractility and protein tyrosine phosphorylation.

Authors:  A K Srivastava; J St-Louis
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

6.  Decavanadate possesses alpha-adrenergic agonist activity and a structural motif common with trans-beta form of noradrenaline.

Authors:  B V Venkataraman; H N Ravishankar; A V Rao; P Kalyani; G Sharada; K Namboodiri; B Gabor; T Ramasarma
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

7.  Analysis of the relaxant effects of AH 21-132 in guinea-pig isolated trachealis.

Authors:  R C Small; J P Boyle; S Duty; K R Elliott; R W Foster; A J Watt
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

8.  Functional role of sodium pump in human placental arteries.

Authors:  M S Fernández-Alfonso; C F Sánchez-Ferrer; M Salaices; J Marín
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

9.  Regulation of vascular and gastric smooth muscle contractility by pervanadate.

Authors:  A Laniyonu; M Saifeddine; S Ahmad; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

Review 10.  Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.

Authors:  Ferdinandos Skoulidis; John V Heymach
Journal:  Nat Rev Cancer       Date:  2019-08-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.